{
  "title": "MSSA Mayhem ü¶†üî´",
  "createdAt": {
    "seconds": 1745589681,
    "nanoseconds": 615000000
  },
  "updatedAt": {
    "seconds": 1745589681,
    "nanoseconds": 615000000
  },
  "scenarios": {
    "OPT10": {
      "name": "VancomycinEmp",
      "text": "You start Vancomycin. It covers both MRSA (methicillin-resistant Staphylococcus aureus) and MSSA (methicillin-sensitive Staphylococcus aureus), and is a reasonable empiric choice in settings with high MRSA prevalence.\n\nHowever, Vancomycin is less effective than beta-lactams for treating MSSA. Studies have shown worse outcomes in patients treated with Vancomycin when the pathogen was actually sensitive.\n\nThe next day, sensitivities return: the bug is MSSA.",
      "options": [
        {
          "text": "start",
          "id": "OPT4"
        }
      ]
    },
    "OPT3": {
      "name": "NafcillinEmp",
      "options": [
        {
          "text": "start",
          "id": "OPT4"
        }
      ],
      "text": "You start Nafcillin. This beta-lactam is highly effective against MSSA (methicillin-sensitive Staphylococcus aureus), but it does not cover MRSA (methicillin-resistant Staphylococcus aureus).\n\nThe next day, sensitivities return: the bug is MSSA."
    },
    "OPT0": {
      "text": "On a chilly evening, while sipping your chamomile tea with honey in the internal medicine staff room where you work as a physician assistant,\nsuddenly the phone rings. After confirming (damn it) that there‚Äôs no one else around to answer, you pick up the receiver:\n\"Hello, this is the microbiology lab. Mr. Nehmadi Nehmad has Staphylococcus aureus in his blood culture. Sensitivities will be ready tomorrow. Got it?\"\n\"Got it.\"\n\nWhat treatment would you recommend the on-call resident start for the nice gentleman?",
      "options": [
        {
          "id": "OPT1",
          "text": "empiric"
        }
      ],
      "name": "intro"
    },
    "OPT6": {
      "options": [
        {
          "id": "OPT0",
          "text": "Restart"
        }
      ],
      "name": "Cefazolin",
      "text": "A golden choice! You switch to Cefazolin, and your patient is afebrile in 48 hours.\nüéâ You win! Stewardship hero, kidney saver."
    },
    "OPT4": {
      "name": "start",
      "text": "Your senior looks at you. ‚ÄúYour call. What‚Äôs the best antibiotic?‚Äù",
      "options": [
        {
          "text": "Vancomycin",
          "id": "OPT5"
        },
        {
          "text": "Cefazolin",
          "id": "OPT6"
        },
        {
          "id": "OPT7",
          "text": "Nafcillin"
        },
        {
          "id": "OPT8",
          "text": "Daptomycin"
        }
      ]
    },
    "OPT9": {
      "name": "Ceftriaxone",
      "options": [
        {
          "id": "OPT0",
          "text": "Restart"
        }
      ],
      "text": "You go with Ceftriaxone ‚Äî a noble empiric bet, broad yet elegant.\n‚ùå Nice try, but let‚Äôs tighten that spectrum."
    },
    "OPT7": {
      "options": [
        {
          "id": "OPT0",
          "text": "Restart"
        }
      ],
      "text": "Ah, the OG anti-staph agent. It works fast ‚Äî the patient improves.\n‚úÖ Good choice medically ‚Äî just don‚Äôt forget the toxicity price tag.",
      "name": "Nafcillin"
    },
    "OPT8": {
      "text": "You opt for the Bugatti of antibiotics: Daptomycin.\n‚ùå Next time, save Daptomycin for when it‚Äôs actually needed.",
      "options": [
        {
          "id": "OPT0",
          "text": "Restart"
        }
      ],
      "name": "Daptomycin"
    },
    "OPT2": {
      "options": [
        {
          "id": "OPT4",
          "text": "start"
        }
      ],
      "text": "You start Cefazolin. It is the drug of choice for MSSA (methicillin-sensitive Staphylococcus aureus), but it does not cover MRSA (methicillin-resistant Staphylococcus aureus).\n\nIt‚Äôs a great option for empiric treatment in patients without risk factors for MRSA and in areas where MRSA prevalence is low.\n\nThe next day, sensitivities return: the bug is MSSA.",
      "name": "CefazolinEmp"
    },
    "OPT5": {
      "text": "You boldly choose Vancomycin. After all, it worked for MRSA once, right?\nThree days later: The cultures are still positive. The creatinine creeps up.\n‚ùå MSSA + Vancomycin = not your best combo.",
      "options": [
        {
          "id": "OPT0",
          "text": "Restart"
        }
      ],
      "name": "Vancomycin"
    },
    "OPT1": {
      "text": "You consider empiric treatment options. It‚Äôs nighttime, sensitivities aren‚Äôt back yet, and all eyes are on you.\nWhat do you start for now?",
      "options": [
        {
          "text": "Vancomycin",
          "id": "OPT10"
        },
        {
          "id": "OPT2",
          "text": "Cefazolin"
        },
        {
          "id": "OPT3",
          "text": "Nafcillin"
        },
        {
          "text": "Ceftriaxone",
          "id": "OPT9"
        }
      ],
      "name": "empiric"
    }
  },
  "drugInfo": {
    "Nafcillin": {
      "PK": "IV, hepatic metabolism",
      "Toxicities": "Interstitial nephritis, phlebitis, liver enzyme elevations",
      "Spectrum": "MSSA only"
    },
    "Cefazolin": {
      "Spectrum": "MSSA, Streptococci",
      "Toxicities": "Rare hypersensitivity, generally well tolerated",
      "PK": "Time-dependent killing, IV, renally cleared"
    },
    "Vancomycin": {
      "Toxicities": "Nephrotoxicity, red man syndrome",
      "Spectrum": "Gram-positive, including MRSA",
      "PK": "Time-dependent killing, IV only, renal clearance"
    },
    "Daptomycin": {
      "Spectrum": "MRSA, VRE",
      "Toxicities": "Myopathy, requires CK monitoring",
      "PK": "Concentration-dependent killing, inactivated by lung surfactant"
    },
    "Ceftriaxone": {
      "Toxicities": "Biliary sludging, GI upset, rash",
      "PK": "Time-dependent killing, IV/IM, hepatic and renal elimination",
      "Spectrum": "Broad Gram-negative and some Gram-positive"
    }
  },
  "summary": {
    "points": [
      "Empiric therapy for suspected Staph aureus bacteremia often starts with vancomycin to cover MRSA.",
      "Once MSSA is confirmed, de-escalate to a beta-lactam such as cefazolin for superior efficacy and lower toxicity.",
      "Vancomycin is linked to nephrotoxicity and the infusion-related ‚Äúred man syndrome.‚Äù",
      "Daptomycin should be reserved for resistant Gram-positive infections and requires CK monitoring.",
      "Good antimicrobial stewardship means promptly narrowing therapy based on culture & sensitivity results."
    ]
  },
  "quiz": {
    "choices": [
      {
        "question": "1. Which antibiotic is the first-line definitive therapy for confirmed MSSA bloodstream infections?",
        "correct": "Cefazolin",
        "id": "Q1",
        "options": [
          "Vancomycin",
          "Cefazolin",
          "Daptomycin"
        ]
      },
      {
        "id": "Q2",
        "question": "2. Which adverse event is characteristically associated with rapid vancomycin infusion?",
        "correct": "Red man syndrome",
        "options": [
          "Red man syndrome",
          "Tendon rupture",
          "Interstitial nephritis"
        ]
      },
      {
        "id": "Q3",
        "options": [
          "Daptomycin",
          "Ceftriaxone",
          "Nafcillin"
        ],
        "correct": "Daptomycin",
        "question": "3. Which antibiotic is inactivated by lung surfactant?"
      },
      {
        "id": "Q4",
        "correct": "Daptomycin",
        "question": "4. Which antibiotic requires creatine kinase monitoring due to risk of myopathy?",
        "options": [
          "Daptomycin",
          "Vancomycin",
          "Cefazolin"
        ]
      }
    ]
  }
}